The Europe Plasma Protein Therapeutics Market would witness market growth of 5.1% CAGR during the forecast period (2023-2029).
Plasma fractionation has changed from a mostly local community-focused medical care activity to a manufacturing sector that complies with strict regulatory requirements. These stringent criteria begin with the plasma collection for fractionation and extend to the production and distribution of products.
Proteins that are lacking or insufficient are replaced by plasma-derived therapies, enabling patients to live healthier, more productive lives. Most patients who depend on these treatments need ongoing infusions or injections. Plasma protein treatments are used to treat rare diseases and ailments, most of which are inherited, chronic conditions that only impact a small percentage of the population.
The plasma-derived therapies business helps to sustain the European economy. The industry's manufacture of plasma-derived medicines is directly impacted by economics. Subcontractors to the blood plasma-derived therapies sector, such as those at plasma collection facilities, cleaning businesses, or IT solution providers, are responsible for the indirect consequences. Induced effects are the value produced for industry workers and subcontractors. In order to grasp the magnitude, figures for these impacts have also been generated. The direct effects alone may exceed three billion euros, and the indirect and induced effects may roughly triple the total economic contribution. Therefore, the region presents lucrative growth opportunities for market advancement.
The Germany market dominated the Europe Plasma Protein Therapeutics Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $2,565.8 Million by 2029. The UK market is anticipated to grow at a CAGR of 4.2% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 5.9% during (2023 - 2029).
Based on End User, the market is segmented into Hospitals, and Others. Based on Product Type, the market is segmented into Immunoglobulin, Albumin, Plasma derived factor VIII, and Others. Based on Application, the market is segmented into Hemophilia, Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Plasma Protein Therapeutics Market is Projected to reach USD 39.1 Billion by 2029, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Abeona Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Grifols, S.A., Baxter International, Inc., Kedrion S.p.A, Octapharma AG, CSL Limited (CSL Behring), Taibang Biological Group Co., Ltd and ADMA Biologics, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
By Product Type
- Immunoglobulin
- Albumin
- Plasma derived factor VIII
- Others
By Application
- Hemophilia
- Idiopathic Thrombocytopenic Purpura
- Primary Immunodeficiency Disorder
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Bayer AG
- Abeona Therapeutics, Inc.
- Takeda Pharmaceutical Company Limited
- Grifols, S.A.
- Baxter International, Inc.
- Kedrion S.p.A
- Octapharma AG
- CSL Limited (CSL Behring)
- Taibang Biological Group Co., Ltd
- ADMA Biologics, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Plasma Protein Therapeutics Market, by End User
1.4.2 Europe Plasma Protein Therapeutics Market, by Product Type
1.4.3 Europe Plasma Protein Therapeutics Market, by Application
1.4.4 Europe Plasma Protein Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
3.3.2 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun – 2023, Mar) Leading Players
Chapter 4. Europe Plasma Protein Therapeutics Market by End User
4.1 Europe Hospitals Market by Country
4.2 Europe Others Market by Country
Chapter 5. Europe Plasma Protein Therapeutics Market by Product Type
5.1 Europe Immunoglobulin Market by Country
5.2 Europe Albumin Market by Country
5.3 Europe Plasma derived factor VIII Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Plasma Protein Therapeutics Market by Application
6.1 Europe Hemophilia Market by Country
6.2 Europe Idiopathic Thrombocytopenic Purpura Market by Country
6.3 Europe Primary Immunodeficiency Disorder Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Plasma Protein Therapeutics Market by Country
7.1 Germany Plasma Protein Therapeutics Market
7.1.1 Germany Plasma Protein Therapeutics Market by End User
7.1.2 Germany Plasma Protein Therapeutics Market by Product Type
7.1.3 Germany Plasma Protein Therapeutics Market by Application
7.2 UK Plasma Protein Therapeutics Market
7.2.1 UK Plasma Protein Therapeutics Market by End User
7.2.2 UK Plasma Protein Therapeutics Market by Product Type
7.2.3 UK Plasma Protein Therapeutics Market by Application
7.3 France Plasma Protein Therapeutics Market
7.3.1 France Plasma Protein Therapeutics Market by End User
7.3.2 France Plasma Protein Therapeutics Market by Product Type
7.3.3 France Plasma Protein Therapeutics Market by Application
7.4 Russia Plasma Protein Therapeutics Market
7.4.1 Russia Plasma Protein Therapeutics Market by End User
7.4.2 Russia Plasma Protein Therapeutics Market by Product Type
7.4.3 Russia Plasma Protein Therapeutics Market by Application
7.5 Spain Plasma Protein Therapeutics Market
7.5.1 Spain Plasma Protein Therapeutics Market by End User
7.5.2 Spain Plasma Protein Therapeutics Market by Product Type
7.5.3 Spain Plasma Protein Therapeutics Market by Application
7.6 Italy Plasma Protein Therapeutics Market
7.6.1 Italy Plasma Protein Therapeutics Market by End User
7.6.2 Italy Plasma Protein Therapeutics Market by Product Type
7.6.3 Italy Plasma Protein Therapeutics Market by Application
7.7 Rest of Europe Plasma Protein Therapeutics Market
7.7.1 Rest of Europe Plasma Protein Therapeutics Market by End User
7.7.2 Rest of Europe Plasma Protein Therapeutics Market by Product Type
7.7.3 Rest of Europe Plasma Protein Therapeutics Market by Application
Chapter 8. Company Profiles
8.1 Bayer AG
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 Grifols, S.A
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Geographical Expansions:
8.3 Takeda Pharmaceutical Company Limited
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.3.5.3 Geographical Expansions:
8.4 Kedrion S.p.A
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 ADMA Biologics, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 Octapharma AG
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Approvals and Trials:
8.7 CSL Limited (CSL Behring)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Baxter International, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Abeona Therapeutics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Research & Development Expenses
8.10. Taibang Biologic Group
8.10.1 Company Overview
TABLE 1 Europe Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 2 Europe Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Plasma Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Plasma Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Plasma Protein Therapeutics Market
TABLE 6 Geographical expansions – Plasma Protein Therapeutics Market
TABLE 7 approvals and trials – Plasma Protein Therapeutics Market
TABLE 8 Europe Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 9 Europe Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 10 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 11 Europe Hospitals Market by Country, 2023 - 2029, USD Million
TABLE 12 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 13 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 14 Europe Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 15 Europe Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 16 Europe Immunoglobulin Market by Country, 2019 - 2022, USD Million
TABLE 17 Europe Immunoglobulin Market by Country, 2023 - 2029, USD Million
TABLE 18 Europe Albumin Market by Country, 2019 - 2022, USD Million
TABLE 19 Europe Albumin Market by Country, 2023 - 2029, USD Million
TABLE 20 Europe Plasma derived factor VIII Market by Country, 2019 - 2022, USD Million
TABLE 21 Europe Plasma derived factor VIII Market by Country, 2023 - 2029, USD Million
TABLE 22 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 23 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 24 Europe Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 25 Europe Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 26 Europe Hemophilia Market by Country, 2019 - 2022, USD Million
TABLE 27 Europe Hemophilia Market by Country, 2023 - 2029, USD Million
TABLE 28 Europe Idiopathic Thrombocytopenic Purpura Market by Country, 2019 - 2022, USD Million
TABLE 29 Europe Idiopathic Thrombocytopenic Purpura Market by Country, 2023 - 2029, USD Million
TABLE 30 Europe Primary Immunodeficiency Disorder Market by Country, 2019 - 2022, USD Million
TABLE 31 Europe Primary Immunodeficiency Disorder Market by Country, 2023 - 2029, USD Million
TABLE 32 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 33 Europe Others Market by Country, 2023 - 2029, USD Million
TABLE 34 Europe Plasma Protein Therapeutics Market by Country, 2019 - 2022, USD Million
TABLE 35 Europe Plasma Protein Therapeutics Market by Country, 2023 - 2029, USD Million
TABLE 36 Germany Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 37 Germany Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 38 Germany Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 39 Germany Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 40 Germany Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 41 Germany Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 42 Germany Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 43 Germany Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 44 UK Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 45 UK Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 46 UK Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 47 UK Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 48 UK Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 49 UK Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 50 UK Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 51 UK Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 52 France Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 53 France Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 54 France Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 55 France Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 56 France Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 57 France Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 58 France Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 59 France Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 60 Russia Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 61 Russia Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 62 Russia Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 63 Russia Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 64 Russia Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 65 Russia Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 66 Russia Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 67 Russia Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 68 Spain Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 69 Spain Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 70 Spain Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 71 Spain Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 72 Spain Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 73 Spain Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 74 Spain Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 75 Spain Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 76 Italy Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 77 Italy Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 78 Italy Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 79 Italy Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 80 Italy Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 81 Italy Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 82 Italy Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 83 Italy Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 84 Rest of Europe Plasma Protein Therapeutics Market, 2019 - 2022, USD Million
TABLE 85 Rest of Europe Plasma Protein Therapeutics Market, 2023 - 2029, USD Million
TABLE 86 Rest of Europe Plasma Protein Therapeutics Market by End User, 2019 - 2022, USD Million
TABLE 87 Rest of Europe Plasma Protein Therapeutics Market by End User, 2023 - 2029, USD Million
TABLE 88 Rest of Europe Plasma Protein Therapeutics Market by Product Type, 2019 - 2022, USD Million
TABLE 89 Rest of Europe Plasma Protein Therapeutics Market by Product Type, 2023 - 2029, USD Million
TABLE 90 Rest of Europe Plasma Protein Therapeutics Market by Application, 2019 - 2022, USD Million
TABLE 91 Rest of Europe Plasma Protein Therapeutics Market by Application, 2023 - 2029, USD Million
TABLE 92 Key Information – Bayer AG
TABLE 93 Key information – Grifols, S.A.
TABLE 94 Key Information – Takeda Pharmaceutical Company Limited
TABLE 95 key Information – Kedrion S.p.A
TABLE 96 Key Information – ADMA Biologics, Inc.
TABLE 97 Key Information – Octapharma AG
TABLE 98 key Information – CSL Limited
TABLE 99 Key Information – Baxter International, Inc.
TABLE 100 Key Information – Abeona Therapeutics, Inc.
TABLE 101 Key Information – Taibang Biologic Group
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Key Strategic Move: (Acquisitions and Mergers : 2020, Jun – 2023, Mar) Leading Players
FIG 5 Swot analysis: bayer ag
FIG 6 Recent strategies and developments: Grifols, S.A.
FIG 7 Recent strategies and developments: Takeda Pharmaceutical Company Limited
FIG 8 Recent strategies and developments: Kedrion S.p.A